Patient Care: Devices, Diagnostics & Medicines

Own the businesses that diagnose, treat and manage patient illness, with medical technology at the basket's center rather than a drug-pipeline bet. The recent technology drawdown makes established healthcare businesses an alternative worth considering, while upcoming results can test whether operating resilience supports their valuations. Reimbursement pressure, procedure demand and product execution remain the principal risks. Launch basket (equal weight): MDT, JNJ, TMO, UNH, LLY, ABT, BSX, SYK, GEHC, ISRG Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.